Benign prostatic hyperplasia (BPH) is a non-cancerous condition that occurs when the prostate enlarges and constricts or obstructs urine flow. BPH affects nearly half of men over age 50 and approximately 80 percent of men in their 80s.
Traditional treatment methods include medications and surgery, such as transurethral resection of the prostate (TURP) or open simple prostatectomy.
Baylor Scott & White offers a new, minimally invasive procedure called Holmium Laser Enucleation of the Prostate (HoLEP), which offers patients immediate improved urine flow in addition to long-term relief